Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Parmiani

Showing results (61-70 of 301) with videos related to

Pageof 31
Sort By:
Immunology Today|October 8, 2014
Allostimulation-induced tumor cytotoxic cells: from mouse to manG Parmiani, M Sensi, G Fossati
Melanoma Research|August 1, 1997
New tumour-restricted melanoma antigens as defined by cytotoxic T-cell responsesG Parmiani, A Anichini, C Castelli
International Journal of Cancer|October 15, 1980
Expression of alien minor histocompatibility antigens distinct from tumor-specific transplantation antigen on a murine fibrosarcomaG Parmiani, M Colombo, D Ballinari
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Analysis of the cellular immune response to and adoptive immunotherapy of a BALB/c lymphoma that cross-reacts with normal DBA/2 cellsM Sensi, L Grazioli, G Parmiani
The Journal of Experimental Medicine|January 1, 1986
Heterogeneity of clones from a human metastatic melanoma detected by autologous cytotoxic T lymphocyte clonesA Anichini, G Fossati, G Parmiani
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|October 1, 1992
Beta 1-integrins on melanoma clones regulate the interaction with autologous cytolytic T-cell clonesA Anichini, R Mortarini, G Parmiani
Tumori|February 24, 2001
Cancer vaccinesM Carrabba, G Parmiani, L Rivoltini
Immunology Today|October 8, 2014
Clonal analysis of the cytolytic T-cell response to human tumorsA Anichini, G Fossati, G Parmiani
Journal of the National Cancer Institute|March 7, 1990
Cellular immune response against autologous human malignant melanoma: are in vitro studies providing a framework for a more effective immunotherapy?G Parmiani, A Anichini, G Fossati
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Influence of the donors' clinical status on in vitro and in vivo tumor-cytotoxic activation of interleukin-2-exposed lymphocytes and their circulation in different organsM Rodolfo, C Salvi, G Parmiani
Pageof 31

Showing results (61-70 of 301) with videos related to

Sort By:
Pageof 31
Immunology Today|October 8, 2014
Allostimulation-induced tumor cytotoxic cells: from mouse to manG Parmiani, M Sensi, G Fossati
Melanoma Research|August 1, 1997
New tumour-restricted melanoma antigens as defined by cytotoxic T-cell responsesG Parmiani, A Anichini, C Castelli
International Journal of Cancer|October 15, 1980
Expression of alien minor histocompatibility antigens distinct from tumor-specific transplantation antigen on a murine fibrosarcomaG Parmiani, M Colombo, D Ballinari
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Analysis of the cellular immune response to and adoptive immunotherapy of a BALB/c lymphoma that cross-reacts with normal DBA/2 cellsM Sensi, L Grazioli, G Parmiani
The Journal of Experimental Medicine|January 1, 1986
Heterogeneity of clones from a human metastatic melanoma detected by autologous cytotoxic T lymphocyte clonesA Anichini, G Fossati, G Parmiani
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|October 1, 1992
Beta 1-integrins on melanoma clones regulate the interaction with autologous cytolytic T-cell clonesA Anichini, R Mortarini, G Parmiani
Tumori|February 24, 2001
Cancer vaccinesM Carrabba, G Parmiani, L Rivoltini
Immunology Today|October 8, 2014
Clonal analysis of the cytolytic T-cell response to human tumorsA Anichini, G Fossati, G Parmiani
Journal of the National Cancer Institute|March 7, 1990
Cellular immune response against autologous human malignant melanoma: are in vitro studies providing a framework for a more effective immunotherapy?G Parmiani, A Anichini, G Fossati
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Influence of the donors' clinical status on in vitro and in vivo tumor-cytotoxic activation of interleukin-2-exposed lymphocytes and their circulation in different organsM Rodolfo, C Salvi, G Parmiani
Pageof 31